NEWEGG COMMERCE INC (NEGG)

VGG6483G1000 - Common Stock

0.4771  0 (-0.62%)

Fundamental Rating

2

NEGG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. NEGG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NEGG does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

NEGG had negative earnings in the past year.
In the past year NEGG had a positive cash flow from operations.
NEGG had negative earnings in 4 of the past 5 years.
In the past 5 years NEGG reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -15.59%, NEGG is doing worse than 77.69% of the companies in the same industry.
NEGG's Return On Equity of -51.46% is on the low side compared to the rest of the industry. NEGG is outperformed by 70.25% of its industry peers.
Industry RankSector Rank
ROA -15.59%
ROE -51.46%
ROIC N/A
ROA(3y)-5.54%
ROA(5y)-53.12%
ROE(3y)-20.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 11.19%, NEGG is not doing good in the industry: 91.74% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for NEGG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

NEGG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NEGG has been increased compared to 1 year ago.
Compared to 5 years ago, NEGG has more shares outstanding
NEGG has a worse debt/assets ratio than last year.

2.2 Solvency

NEGG has an Altman-Z score of 3.31. This indicates that NEGG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.31, NEGG is in the better half of the industry, outperforming 73.55% of the companies in the same industry.
NEGG has a debt to FCF ratio of 6.86. This is a slightly negative value and a sign of low solvency as NEGG would need 6.86 years to pay back of all of its debts.
NEGG has a Debt to FCF ratio (6.86) which is comparable to the rest of the industry.
NEGG has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, NEGG is in the better half of the industry, outperforming 62.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 6.86
Altman-Z 3.31
ROIC/WACCN/A
WACC10.41%

2.3 Liquidity

NEGG has a Current Ratio of 1.21. This is a normal value and indicates that NEGG is financially healthy and should not expect problems in meeting its short term obligations.
NEGG has a Current ratio (1.21) which is comparable to the rest of the industry.
A Quick Ratio of 0.54 indicates that NEGG may have some problems paying its short term obligations.
NEGG has a Quick ratio of 0.54. This is comparable to the rest of the industry: NEGG outperforms 52.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.54

2

3. Growth

3.1 Past

The earnings per share for NEGG have decreased by -3.89% in the last year.
The Revenue for NEGG has decreased by -12.98% in the past year. This is quite bad
NEGG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 377.98% yearly.
EPS 1Y (TTM)-3.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.81%
Revenue 1Y (TTM)-12.98%
Revenue growth 3Y1452.57%
Revenue growth 5Y377.98%
Sales Q2Q%-14.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.09%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.45%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEGG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NEGG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

NEGG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 57.91
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NEGG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEWEGG COMMERCE INC

NASDAQ:NEGG (12/18/2024, 11:29:07 AM)

0.4771

0 (-0.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap185.08M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.59%
ROE -51.46%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 11.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.96
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.21
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-3.89%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.98%
Revenue growth 3Y1452.57%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y